Delivery Order SPE2DB20D3103-SPE2DB25FP1F2

Award Date 6/11/25
Potential Completion Date 6/12/25
Potential Value $7.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BIKTARVY 50-200-25 MG TABLET in units of 30s, with a ceiling value of $10,307.47 and a completion date of April 3, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BIKTARVY 50-200-25 MG TABLET in quantities of 30 per unit, with a completion date of May 22, 2025 and a ceiling value of $77,040.83. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET in quantities of 30 per unit, with a ceiling value of $62,460.94 and a period of performance through June 6, 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET in 30-tablet units, with a ceiling value of $7,412.25 and a period of performance ending on June 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication, with a ceiling value of $7,919.29 and a period of performance through May 1, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication, with a ceiling value of $33,187.35 and a period of performance through April 30, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $10,741.23 and a period of performance through March 13, 2025. It is for the procurement of BIKTARVY 50-200-25 MG TABLET, a prescription medication. The contract was awarded as a Firm Fixed Price delivery order, with no set-aside designation. AmerisourceBergen holds a...
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of BIKTARVY 50-200-25 MG TABLET medical products, with a ceiling value of $36,066.84 and a completion date of February 13, 2025. The contract is a firm fixed price delivery order, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a medication, to support federal healthcare programs. The total ceiling value of the order is $6,660.62, with a completion date of December 19, 2024. The contract is a firm fixed-price delivery order, and no set-aside designation is mentioned. AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET in quantities of 30 count. The total ceiling value of the contract is $73,539.46, and it has a firm fixed price pricing type. The contract has an ultimate completion date of September 9, 2024. This delivery order is likely part of a larger Indefinite...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FP1F2
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BIKTARVY 50-200-25 MG TABLET in quantities of 30s, with a ceiling value of $7,322.83 and a completion date of June 12, 2025. The contract is a firm fixed price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 9/10/25, 9:46 AM